Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Wave Life Sciences Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
WVE
Nasdaq
8731
https://www.wavelifesciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Wave Life Sciences Ltd
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
- May 2nd, 2024 12:30 pm
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
- Apr 30th, 2024 12:30 pm
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
- Apr 23rd, 2024 12:30 pm
Wave Life Sciences to Present at Upcoming Investor Conferences
- Mar 27th, 2024 12:30 pm
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
- Mar 15th, 2024 12:18 pm
Wave Life Sciences Ltd. (NASDAQ:WVE) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
- Mar 9th, 2024 1:46 pm
We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth
- Mar 8th, 2024 10:43 am
Wave Life Sciences Full Year 2023 Earnings: Beats Expectations
- Mar 8th, 2024 10:40 am
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 3:47 pm
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 6th, 2024 12:30 pm
Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024
- Feb 28th, 2024 1:30 pm
Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains?
- Feb 28th, 2024 9:16 am
Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy
- Feb 27th, 2024 1:30 pm
The past five years for Wave Life Sciences (NASDAQ:WVE) investors has not been profitable
- Jan 23rd, 2024 12:23 pm
Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones
- Jan 8th, 2024 1:00 pm
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 1:30 pm
Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy
- Dec 15th, 2023 1:30 pm
Wave Life Sciences Ltd.'s (NASDAQ:WVE) recent 35% pullback adds to one-year year losses, institutional owners may take drastic measures
- Dec 13th, 2023 10:44 am
Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
- Dec 7th, 2023 12:00 pm
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
- Dec 6th, 2023 9:10 pm
Scroll